|
BioProcessing Inc., located in scenic Portland, Maine, is a primary manufacturer of specialized raw materials for use in the Diagnostic Industry. Our product line includes novel tumor marker proteins, monoclonal antibodies and diagnostic control serums for clinically approved and novel immuno-assays. In addition, BioProcessing also provides Contract Hybridoma and in-vitro large-scale Cell Culture services for the Biotechnology Industry.
BioProcessing, Inc. is a manufacturer of tumor marker antigens and antibodies to Ca15-3, Ca27.29, breast tumor antigens, Ca125, ovarian tumor antigen, Ca19-9, GI tumor antigen, CEA, carcinoembryonic antigen, AFP, alpha fetoprotein, Ca72.4, Tag-72, Cyfra21-1, cytokeratin-19, PSA, prostate specific antigen using cell culture technologies.
 This division of BioProcessing, Inc., begun in 2000, is specialized in the in vitro production of proteins and antibodies from human, mammalian, bacterial and hybridoma cell lines. We draw from our nearly 14 years of tumor marker cell culture production and purification experience to offer our highly specialized expertise to companies who need oncology related assay reagents. Contract manufacturing using bioreactor technology, hybridoma development and protein purification.
|
|
